In the SOD1G93A mouse model of ALS, treatment with polyamines, potent inhibitors of LSD1, rescued the LSD1-H3K4me2 pathway, prevented motoneuron degeneration, and improved motor performance and survival [102]. Here, KDM1A is linked to amyotrophic lateral sclerosis.